CVRX Financials: CVRx Inc AI Analysis



Financials

CVRX Financial

CVRx Inc

$5.27

-23.84%

$-1.65

At close: May 12, 16:00:00 GMT-4

$5.37

1.89%

$0.1

Post-market: May 12, 16:49:34 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$6.92

Open

$6.86

Day's Range

$5.21 - $6.86

52 week range

$4.29 - $11.3

Volume

857.0K

Avg.Volume

322.7K

Dividend yield

EPS (TTM)

-2.44

Market Cap

$141.2M

What is CVRX?

CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company is headquartered in Minneapolis, Minnesota and currently employs 206 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The firm's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.

Features

Markets

News

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	56	16	14	13	12	15
Revenue Growth (YoY)	10%	7%	8%	18%	20%	36%
Cost of Revenue	8	2	1	2	2	2
Gross Profit	48	13	12	11	10	12
Selling, General & Admin	88	22	21	23	21	20
Research & Development	11	3	3	2	2	2
Operating Expenses	99	25	25	25	23	23
Other Non Operating Income (Expenses)	3	0	0	1	1	1
Pretax Income	-53	-11	-12	-14	-13	-10
Income Tax Expense	0	0	0	0	0	0
Net Income	-53	-11	-12	-14	-13	-10
Net Income Growth	-10%	10%	-8%	0%	-41%	11%
Shares Outstanding (Diluted)	26.21	26.21	26.16	26.07	25.87	24.73
Shares Change (YoY)	6%	6%	15%	21%	22%	19%
EPS (Diluted)	-2.04	-0.45	-0.49	-0.56	-0.53	-0.43
EPS Growth	-16%	6%	-14%	-13%	-49%	-2%
Free Cash Flow	-40	-9	-10	-8	-12	-8
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	85.71%	81.25%	85.71%	84.61%	83.33%	80%
Operating Margin	-91.07%	-68.75%	-85.71%	-107.69%	-108.33%	-66.66%
Profit Margin	-94.64%	-68.75%	-85.71%	-107.69%	-108.33%	-66.66%
Free Cash Flow Margin	-71.42%	-56.25%	-71.42%	-61.53%	-100%	-53.33%
EBITDA	-51	-11	-12	-14	-13	-10
EBITDA Margin	-91.07%	-68.75%	-85.71%	-107.69%	-108.33%	-66.66%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-51	-11	-12	-14	-13	-10
EBIT Margin	-91.07%	-68.75%	-85.71%	-107.69%	-108.33%	-66.66%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Breakdown

TTM

12/31/2025

09/30/2025

06/30/2025

03/31/2025

12/31/2024

Revenue

Revenue Growth (YoY)

10%

18%

20%

36%

Cost of Revenue

Gross Profit

Selling, General & Admin

Research & Development

Operating Expenses

Other Non Operating Income (Expenses)

Pretax Income

-53

-11

-12

-14

-13

-10

Income Tax Expense

Net Income

-53

-11

-12

-14

-13

-10

Net Income Growth

-10%

10%

-8%

-41%

11%

Shares Outstanding (Diluted)

26.21

26.16

26.07

25.87

24.73

Shares Change (YoY)

15%

21%

22%

19%

EPS (Diluted)

-2.04

-0.45

-0.49

-0.56

-0.53

-0.43

EPS Growth

-16%

-14%

-13%

-49%

-2%

Free Cash Flow

-40

-9

-10

-8

-12

-8

Free Cash Flow Per Share

Gross Margin

85.71%

81.25%

85.71%

84.61%

83.33%

80%

Operating Margin

-91.07%

-68.75%

-85.71%

-107.69%

-108.33%

-66.66%

Profit Margin

-94.64%

-68.75%

-85.71%

-107.69%

-108.33%

-66.66%

Free Cash Flow Margin

-71.42%

-56.25%

-71.42%

-61.53%

-100%

-53.33%

EBITDA

-51

-11

-12

-14

-13

-10

EBITDA Margin

-91.07%

-68.75%

-85.71%

-107.69%

-108.33%

-66.66%

D&A For EBITDA

EBIT

-51

-11

-12

-14

-13

-10

EBIT Margin

-91.07%

-68.75%

-85.71%

-107.69%

-108.33%

-66.66%

Effective Tax Rate

Follow-Up Questions

What are CVRx Inc's key financial statements?



According to the latest financial statement (Form-10K), CVRx Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for CVRX?



CVRx Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is CVRx Inc's revenue broken down by segment or geography?



CVRx Inc largest revenue segment is Medical Device, at a revenue of 56,651,000 in the most earnings release.For geography, United States is the primary market for CVRx Inc, at a revenue of 51,883,000.

Is CVRx Inc profitable?



no, according to the latest financial statements, CVRx Inc has a net loss of $0

Does CVRx Inc have any liabilities?



no, CVRx Inc has liability of 0

How many outstanding shares for CVRx Inc?



CVRx Inc has a total outstanding shares of 0

CVRx Inc (CVRX) Financial

CVRX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is CVRX?

CVRx Inc (CVRX) Financial

CVRX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is CVRX?

CVRX Income

Follow-Up Questions

What are CVRx Inc's key financial statements?

What are the key financial ratios for CVRX?

How is CVRx Inc's revenue broken down by segment or geography?

Is CVRx Inc profitable?

Does CVRx Inc have any liabilities?

How many outstanding shares for CVRx Inc?